Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06207240 · ClinicalTrials.gov registry record · NA
Functional Electrical Stimulation Therapy After Stroke
A NA study, sponsored by Battelle Memorial Institute.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT06207240: Completed NA study, sponsored by Battelle Memorial Institute.
NCT06207240 is a NA study that has completed, run by Battelle Memorial Institute. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06207240, a NA study, has completed, sponsored by Battelle Memorial Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The goal of this feasibility study is to test the feasibility of providing task-oriented, intention-driven functional electrical stimulation (FES) using the novel NeuroLife FES Sleeve and NeuroLife electromyography (EMG) and FES Sleeve devices in chronic stroke survivors. The main questions it aims to answer are: * Can these devices be used to administer task-oriented therapy with assistive stimulation at similar doses to current standards of care? * How does therapy using these devices impact the upper limb function in a few chronic stroke survivors? Participants will receive assistive electrical stimulation synchronized to their movement intention while practicing functional tasks with everyday objects over the course of 8 weeks.
Primary Outcome
The Action Research Arm Test (ARAT) will be used to track functional changes from the pre-intervention baseline. The ARAT is a common measure of upper extremity function after stroke ranging from 0 (maximal impairment) to 57 (no impairment).
Interventions
- DEVICE NeuroLife FES Sleeve / NeuroLife EMG-FES Sleeve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2022-01-18 |
| Est. Completion | 2022-06-08 |
| Phase | NA |
What the finished NCT06207240 record still lists
NCT06207240 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which NeuroLife FES Sleeve / NeuroLife EMG-FES Sleeve is the first listed.
NCT06207240 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06207240 about?
NCT06207240 is a clinical study titled "Functional Electrical Stimulation Therapy After Stroke". The goal of this feasibility study is to test the feasibility of providing task-oriented, intention-driven functional electrical stimulation (FES) using the novel NeuroLife FES Sleeve and NeuroLife electromyography (EMG) and FES Sleeve devices in chronic stroke survivors. The main questions it aims ...
What is the current status of trial NCT06207240?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2022-01-18. Estimated completion is 2022-06-08.
What interventions are being tested in trial NCT06207240?
The interventions under investigation include: NeuroLife FES Sleeve / NeuroLife EMG-FES Sleeve (DEVICE).
Who is sponsoring clinical trial NCT06207240?
This trial is sponsored by Battelle Memorial Institute, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06207240's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI